BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15717883)

  • 1. A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects.
    Wang XL; Lu JM; Pan CY; Tian H; Li CL
    Diabet Med; 2005 Mar; 22(3):332-5. PubMed ID: 15717883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study comparing the prevalence of urinary albumin excretion and microalbuminuria in pre-diabetes subjects].
    Wang XL; Lu JM; Pan CY; Tian H
    Zhonghua Nei Ke Za Zhi; 2004 Mar; 43(3):170-3. PubMed ID: 15059368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and predictors of microalbuminuria in persons with various glucose tolerance levels].
    Huo L; Xu M; Huang HE; Li R; Dai M; Wang JG; Ning G; Li XY
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2537-40. PubMed ID: 18067826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure.
    Hoffmann IS; Jimenez E; Cubeddu LX
    J Hum Hypertens; 2001 Jun; 15(6):407-12. PubMed ID: 11439316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Tapp RJ; Shaw JE; Zimmet PZ; Balkau B; Chadban SJ; Tonkin AM; Welborn TA; Atkins RC
    Am J Kidney Dis; 2004 Nov; 44(5):792-8. PubMed ID: 15492944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease.
    Heldgaard PE; Olivarius Nde F; Hindsberger C; Henriksen JE
    Diabet Med; 2004 Apr; 21(4):363-70. PubMed ID: 15049940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease.
    Marín R; Rodríguez P; Tranche S; Redón J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Lozano JV; Filozof C;
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S178-88. PubMed ID: 17130259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria in non-insulin-dependent diabetes.
    Mogensen CE; Damsgaard EM; Frøland A; Nielsen S; de Fine Olivarius N; Schmitz A
    Clin Nephrol; 1992; 38 Suppl 1():S28-39. PubMed ID: 1295705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-challenge hyperglycaemia is an independent risk factor for arterial stiffness in Japanese men.
    Ohshita K; Yamane K; Ishida K; Watanabe H; Okubo M; Kohno N
    Diabet Med; 2004 Jun; 21(6):636-9. PubMed ID: 15154954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary albumin excretion in patients with essential hypertension and impaired glucose tolerance].
    Cymerys M; Miczke A; Bogdański P; Pupek-Musialik D
    Pol Merkur Lekarski; 2003 Dec; 15(90):530-3. PubMed ID: 15058254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in prevalence and 6-year incidence of diabetes and impaired fasting glucose in Korean subjects living in a rural area.
    Song KH; Nam-Goomg IS; Han SM; Kim MS; Lee EJ; Lee YS; Lee MS; Yoon S; Lee KU; Park JY
    Diabetes Res Clin Pract; 2007 Dec; 78(3):378-84. PubMed ID: 17544540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.
    Lu B; Wen J; Song XY; Dong XH; Yang YH; Zhang ZY; Zhao NQ; Ye HY; Mou B; Chen FL; Liu Y; Shen Y; Wang XC; Zhou LN; Li YM; Zhu XX; Hu RM
    Diabetes Res Clin Pract; 2007 Feb; 75(2):184-92. PubMed ID: 16893584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.